Скачать или смотреть Trump Announces 100% Tariff on Imported Medicines | Will India Be Affected?

U.S. President Donald Trump announced a 100% tariff on imported branded and patented pharmaceutical products, effective October 1, 2025, unless companies are actively building manufacturing facilities in the United States. While generics—most of India’s exports—remain exempt, the policy introduces uncertainty for high-value patented and specialty drugs. Analysts warn that American patients could face higher prices, delays, and reduced access to essential medicines, while hospitals and pharmacies may struggle to maintain supply. For India’s pharma sector, the tariff signals potential future risks as companies increasingly export branded drugs. While the move aims to boost domestic production, reshoring pharmaceuticals will take years and may not offset short-term pain for consumers. Trump’s sweeping tariff is a high-stakes gamble with significant implications for U.S. healthcare and India’s export-driven pharmaceutical industry.

#tarriffonpharma #ushealthcare #pharmaceuticaltariffs #trumptariffs


Welcome to Indiatimes Youtube channel.
Your go-to source for news that matters. We deliver comprehensive coverage of international and national events, diving into politics, lifestyle, and all the trending stories that demand your attention. Stay informed with us.

Follow us on Youtube:    / indiatimes  
Follow us on Instagram:   / indiatimes  
Like us on Facebook:   / indiatimes